The Complete Guide to AI/ML Roles in Drug Discovery

What Are the Core AI/ML Roles in Drug Discovery?

The modern drug discovery pipeline is increasingly powered by artificial intelligence and machine learning at every stage. From identifying a biological target to optimizing a lead compound and predicting its behavior in humans, AI has moved from an experimental add-on to a core capability in pharma R&D. But building an effective drug discovery AI team is not the same as building a tech company's ML team. The domain knowledge requirements are fundamentally different.

Here is where AI fits across the drug discovery pipeline:

• Target identification & validation: Computational biologists use ML on genomics, transcriptomics, and proteomics data to identify disease-relevant targets and validate them with multi-omics evidence.
• Hit finding & virtual screening: Cheminformatics engineers build virtual screening pipelines that evaluate millions of compounds against a target using molecular docking scores, pharmacophore models, and learned molecular representations.
• Lead optimization: Drug discovery ML scientists build models to predict how modifications to a molecule's structure will affect its potency, selectivity, and drug-like properties.
• ADMET prediction: ML models predict absorption, distribution, metabolism, excretion, and toxicity properties before expensive wet-lab assays, saving months and millions in development costs.
• Clinical trial optimization: AI helps with patient stratification, endpoint prediction, and trial design optimization to improve success rates in clinical phases.

Each of these stages requires different AI/ML specializations. A graph neural network expert building molecular property predictors has almost nothing in common with an MLOps engineer ensuring model reproducibility under FDA audit. This guide breaks down each role so hiring managers can build the right team.

What Does a Cheminformatics Engineer Do?

The cheminformatics engineer sits at the intersection of chemistry, data engineering, and machine learning. This role is responsible for transforming molecular structures into machine-readable representations, building virtual screening pipelines, and developing molecular property prediction models that feed directly into drug discovery decisions.

Core Responsibilities

• Building and maintaining virtual screening pipelines that can evaluate millions of compounds against biological targets
• Working with molecular representations: SMILES strings (Simplified Molecular Input Line Entry System), InChI keys, molecular fingerprints (Morgan/ECFP, MACCS keys, topological fingerprints), and 3D conformer generation
• Developing molecular property prediction models for solubility, lipophilicity (logP), permeability, and other drug-like properties
• Curating and standardizing chemical databases, handling tautomers, stereochemistry, salt forms, and charge states
• Integrating with computational chemistry tools for docking, conformer generation, and force-field calculations

Essential Technical Skills

• RDKit: The open-source cheminformatics toolkit—non-negotiable for any cheminformatics role. Used for molecular manipulation, fingerprint generation, substructure searching, and descriptor calculation.
• Open Babel: Chemical file format conversion and molecular manipulation
• Graph neural networks: Message-passing neural networks (MPNN), graph convolutional networks for molecular property prediction, and architectures like SchNet and DimeNet for 3D molecular learning
• Molecular descriptors: Understanding when to use 2D vs 3D descriptors, fingerprint-based vs learned representations
• Python scientific stack: NumPy, pandas, scikit-learn, PyTorch/PyTorch Geometric for molecular ML

Cheminformatics Engineer vs. Computational Chemist

These roles are frequently confused. A cheminformatics engineer is software-first: they build data pipelines, ML models, and tools. A computational chemist is chemistry-first: they run molecular dynamics simulations, quantum mechanical calculations, and free energy perturbation studies. The cheminformatics engineer might use outputs from the computational chemist's simulations as features in an ML model, but the two roles require very different skill sets and training backgrounds.

What Is the Difference Between a Drug Discovery ML Scientist and a General ML Engineer?

This is the most common hiring mistake in pharma AI: assuming a strong general ML engineer can step into a drug discovery ML scientist role without domain knowledge. The technical ML skills may overlap, but the context in which those skills are applied is entirely different. A drug discovery ML scientist must understand why a model's prediction matters biologically, not just whether the loss function is decreasing.

The cost of this confusion is real. We have seen pharma companies hire brilliant ML engineers who spend their first six months learning what a binding affinity is, what IC50 values mean, and why you cannot just throw more data at a molecular property prediction problem when the underlying assays have high variance. For more on avoiding costly hiring missteps like this, see our guide on common pharma AI hiring mistakes.

Why Does Pharma Need Specialized MLOps Engineers?

MLOps in pharma is not the same as MLOps at a tech company. The regulatory environment transforms every aspect of model lifecycle management. Standard MLOps practices—experiment tracking, model versioning, CI/CD pipelines—are necessary but nowhere near sufficient when your models support drug development decisions that will be reviewed by the FDA or EMA.

What Makes Pharma MLOps Different

• GxP compliance: Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP), and Good Clinical Practice (GCP) all have implications for how ML models are developed, validated, and documented. Models used in regulated decision-making must follow validated computational methods with documented SOPs.
• 21 CFR Part 11 compliance: Electronic records and electronic signatures must meet FDA requirements. This means audit trails for every model change, training run, and prediction. Every parameter update, dataset modification, and model deployment must be traceable to a specific person, timestamp, and rationale.
• Model versioning with regulatory context: It is not enough to tag model versions in MLflow. Pharma MLOps must link each model version to the specific training data, validation data, hyperparameters, software environment, and the biological question the model was designed to answer—all in a format suitable for regulatory submission.
• Validation protocols: Models must go through IQ/OQ/PQ (Installation Qualification, Operational Qualification, Performance Qualification) processes similar to laboratory instruments.
• Reproducibility requirements: Regulators may ask to reproduce a model's predictions years after a submission. The entire computational environment must be preserved and documented.

Skills Required

A pharma MLOps engineer needs standard MLOps skills (Docker, Kubernetes, CI/CD, model monitoring) plus deep understanding of regulatory documentation, quality management systems, CSV (Computer System Validation), and data integrity principles (ALCOA+: Attributable, Legible, Contemporaneous, Original, Accurate). This combination is exceptionally rare, which is why these roles command significant salary premiums. See our 2026 healthcare AI salary guide for current compensation benchmarks.

What Role Do Computational Biologists Play in AI Drug Discovery?

Computational biologists are the bridge between biology and artificial intelligence in drug discovery. While cheminformatics engineers work with small molecules and chemical structures, computational biologists work with biological data—genomes, proteomes, transcriptomes, and biological pathways—to identify and validate the targets that drug molecules are designed to hit.

Where They Fit in the Pipeline

Computational biologists are most active in the earliest stages of drug discovery: target identification and target validation. They analyze multi-omics datasets to find genes, proteins, or pathways that are causally linked to disease. Increasingly, they use ML approaches to integrate disparate biological datasets and make predictions about which targets are most likely to be druggable and therapeutically relevant.

Core Skills

• Genomics and transcriptomics: RNA-seq analysis, differential gene expression, GWAS (genome-wide association studies), single-cell RNA sequencing analysis
• Proteomics and structural biology: Protein structure prediction (AlphaFold, ESMFold), protein-protein interaction networks, binding site analysis. For more on how AlphaFold is reshaping pharma talent needs, read our piece on AlphaFold and generative AI in pharma talent.
• Pathway analysis: Gene ontology enrichment, pathway databases (KEGG, Reactome), network biology approaches
• Multi-omics integration: Combining genomics, transcriptomics, proteomics, and metabolomics data using ML methods to build comprehensive disease models
• Bioinformatics tools: Bioconductor, Biopython, sequence alignment tools (BLAST, HMMER), variant calling pipelines
• ML for biology: Sequence-based deep learning (protein language models like ESM-2), graph neural networks for protein interaction networks, transfer learning from large biological foundation models

The typical background for this role is a PhD in computational biology, bioinformatics, systems biology, or a related field, with demonstrated ability to apply ML methods to biological datasets. Wet-lab experience is a significant advantage—computational biologists who have personally run experiments understand data quality issues that purely computational scientists may overlook.

How Do Data Engineers Support Drug Discovery AI Teams?

Drug discovery AI teams generate and consume some of the most heterogeneous data in any industry. A single drug discovery program may involve high-throughput screening assay results (millions of data points), compound structures in SDF and MOL formats, protein crystal structures in PDB format, genomics data in FASTQ/BAM files, microscopy images, flow cytometry data, pharmacokinetic time-course data, and clinical trial outcomes. Making all of this data available, clean, and ML-ready is the job of the pharma data engineer.

Key Challenges

• Data heterogeneity: Assay results, chemical structures, biological sequences, imaging data, and clinical records all use different formats, schemas, and conventions. Integrating these into unified ML-ready datasets requires deep understanding of each data type.
• Data quality and provenance: Lab data is noisy. Assay results vary between plates, between operators, between days. The data engineer must build pipelines that capture this provenance metadata and flag quality issues before they corrupt ML training sets.
• FAIR data principles: Findable, Accessible, Interoperable, Reusable. Pharma companies are increasingly mandating FAIR compliance for internal data, which requires thoughtful schema design, metadata standards, and persistent identifiers.
• LIMS integration: Laboratory Information Management Systems track samples, experiments, and results. Data engineers must build reliable integrations between LIMS platforms and ML infrastructure.
• ELN integration: Electronic Lab Notebooks contain experiment protocols, observations, and unstructured notes that are increasingly being mined with NLP for experimental insights.

Tools and Technologies

Standard data engineering tools (Apache Airflow, Spark, dbt, SQL, cloud platforms) plus domain-specific knowledge of chemical data formats (SDF, MOL, SMILES), biological data formats (FASTA, PDB, FASTQ), assay data management platforms, and regulatory data management requirements. Familiarity with ALCOA+ data integrity principles and audit trail requirements is essential for any data pipeline that feeds into regulated decision-making.

What Skills Should a Pharma AI Team Lead Have?

Leading a drug discovery AI team requires a rare combination of technical depth, scientific domain knowledge, and leadership capability. The team lead must be credible with both ML engineers and medicinal chemists, must understand regulatory constraints without being paralyzed by them, and must translate business objectives (advance this program to IND filing) into concrete AI/ML project plans.

The ideal background for a pharma AI team lead is typically 8-12 years of experience spanning both computational drug discovery and AI/ML, often with a PhD in computational chemistry, bioinformatics, or a related field plus significant industry experience in pharma or biotech AI teams.

How Do All Six Drug Discovery AI Roles Compare?

The table below provides a side-by-side comparison of all six core drug discovery AI roles, including primary focus, key tools, domain knowledge requirements, typical background, and salary ranges.

Salary ranges represent senior-level (6-10 years experience) EUR-equivalent total compensation including base and bonus. Actual figures vary by geography, company stage, and specific sub-specialization. Refer to our 2026 healthcare AI salary guide for detailed regional breakdowns.

Frequently Asked Questions About Drug Discovery AI Roles

Can a general ML engineer transition into drug discovery AI?

Yes, but expect a 6-12 month ramp-up period. The ML skills transfer, but understanding molecular representations, assay data, protein biology, and regulatory requirements takes time. The most successful transitions happen when the engineer is paired with a domain expert (medicinal chemist or biologist) who can provide context. Companies that invest in structured onboarding with domain immersion see much faster transitions than those who expect engineers to self-teach.

Is a PhD required for drug discovery AI roles?

For drug discovery ML scientists and computational biologists, a PhD is strongly preferred because the research training and domain depth are difficult to acquire otherwise. For pharma MLOps engineers and data engineers, a PhD is less important—industry experience with regulated environments and the right technical skills matter more. Cheminformatics engineers fall in between: a master's degree with strong chemistry coursework and RDKit experience can substitute for a PhD in some cases.

What programming languages are most important?

Python dominates drug discovery AI. It is the language of RDKit, DeepChem, BioPython, and nearly all modern ML frameworks. R remains relevant for computational biology (Bioconductor ecosystem) and statistical analysis. SQL is essential for data engineers. C++ knowledge is valuable for cheminformatics engineers who need to optimize molecular processing pipelines for performance. Julia is emerging for some computational chemistry applications but is not yet mainstream.

How do you evaluate domain knowledge in drug discovery AI interviews?

Ask candidates to interpret real outputs. Show a cheminformatics candidate a set of SMILES strings and ask them to identify which molecules are drug-like. Give a drug discovery ML scientist an ADMET prediction result and ask what it means for the compound's viability. Present a computational biologist with a gene expression heatmap and ask which targets they would prioritize. The ability to translate ML outputs into scientific insights is what separates domain-aware candidates from general ML practitioners.

Should a pharma company build an in-house AI team or outsource?

Companies with active drug discovery pipelines should build core in-house AI capability. The tight feedback loop between AI models and wet-lab experiments requires embedded team members who understand the science. Outsourcing works for specific, well-defined projects (building a one-time virtual screening campaign) but fails for ongoing, iterative model development that requires daily interaction with discovery scientists. A hybrid approach—core in-house team supplemented by specialized consultants for niche areas—is often optimal.

What is the biggest challenge in hiring for drug discovery AI?

Talent scarcity at the intersection of AI/ML and life sciences. The total global pool of people with both deep ML expertise and drug discovery domain knowledge is small—estimated at only a few thousand worldwide. This means longer search timelines (typically 3-6 months for senior roles), higher compensation requirements, and the need for creative sourcing strategies including recruiting from adjacent fields and investing in internal training programs.